120 related articles for article (PubMed ID: 16243430)
1. Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor.
Chen JH; Wu CW; Kao HL; Chang HM; Li AF; Liu TY; Chi CW
Cancer Lett; 2006 Aug; 239(2):263-70. PubMed ID: 16243430
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression.
Chen JH; Liu TY; Wu CW; Chi CW
Med Hypotheses; 2001 Oct; 57(4):503-5. PubMed ID: 11601879
[TBL] [Abstract][Full Text] [Related]
3. Effect of hepatocyte growth factor on cell cycle and c-met expression in human gastric cancer cells.
Liu SI; Lui WY; Mok KT; Wu CW; Chi CW
Anticancer Res; 1997; 17(5A):3575-80. PubMed ID: 9413205
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells.
Kanayama S; Yamada Y; Kawaguchi R; Tsuji Y; Haruta S; Kobayashi H
Oncol Rep; 2008 Jan; 19(1):117-22. PubMed ID: 18097584
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4.
Heideman DA; van Beusechem VW; Bloemena E; Snijders PJ; Craanen ME; Offerhaus GJ; Derksen PW; de Bruin M; Witlox MA; Molenaar B; Meijer CJ; Gerritsen WR
J Gene Med; 2004 Mar; 6(3):317-27. PubMed ID: 15026993
[TBL] [Abstract][Full Text] [Related]
7. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells.
Konturek PC; Kania J; Kukharsky V; Ocker S; Hahn EG; Konturek SJ
J Physiol Pharmacol; 2003 Mar; 54(1):17-32. PubMed ID: 12674216
[TBL] [Abstract][Full Text] [Related]
8. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
[TBL] [Abstract][Full Text] [Related]
9. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
Murakami N; Koufuji K; Shirouzu K
Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic study of cigarette smoke and cyclooxygenase-2 on proliferation of gastric cancer cells.
Shin VY; Liu ES; Ye YN; Koo MW; Chu KM; Cho CH
Toxicol Appl Pharmacol; 2004 Feb; 195(1):103-12. PubMed ID: 14962510
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral-mediated gene transduction of the hepatocyte growth factor (HGF) antagonist, NK4, suppresses peritoneal metastases of gastric cancer in nude mice.
Ueda K; Iwahashi M; Matsuura I; Nakamori M; Nakamura M; Ojima T; Naka T; Ishida K; Matsumoto K; Nakamura T; Yamaue H
Eur J Cancer; 2004 Sep; 40(14):2135-42. PubMed ID: 15341989
[TBL] [Abstract][Full Text] [Related]
12. [Expression of hepatocyte growth factor and its receptor in gastric cancer].
Chen JZ; Zhao Y; Xu JF; Liu Q; Liu SH; Zhang HD
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1771-3. PubMed ID: 18024311
[TBL] [Abstract][Full Text] [Related]
13. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
[TBL] [Abstract][Full Text] [Related]
14. c-Met expression in a gastric cancer cell line producing alpha-fetoprotein.
Amemiya H; Kono K; Takahashi A; Kamei S; Sugai H; Ichihara F; Fujii H; Matsumoto Y
Surg Today; 2004; 34(2):115-22. PubMed ID: 14745610
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of the hepatocyte growth factor contributing to lymphangiogenesis and lymphatic metastasis in gastric cancer].
Zhang QH; Qian K; Li XJ; Pu J; Wu XT
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):212-6. PubMed ID: 17520376
[TBL] [Abstract][Full Text] [Related]
16. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
17. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
Colombo ES; Menicucci G; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
[TBL] [Abstract][Full Text] [Related]
20. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C
Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
